Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pharmacy Calls For The FDA To Require Independent Third-Party Testing
Action Follows Assertions That US FDA And Industry Underestimated Metformin Risks
Mar 04 2020
•
By
Joanne S. Eglovitch
Pharmacy Doubts The FDA's Claims On Metformin Drug Safety • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance